Insights

qtq80HYk8Ri1080x675

Board Requires Settlement Agreement to Dismiss Pre-Institution Proceeding, PTAB Litigation Blog

Visit the PTAB Litigation Blog.

Biofrontera AG (“Petitioner”) filed an unopposed motion to dismiss the petition during the preliminary phase of the proceedings.  Here, DUSA Pharmaceuticals, Inc. (“Patent Owner”) had not yet filed a Preliminary Response, and the Board has not issued a decision on whether to institute trial.  But because Petitioner did not file the parties’ recent settlement agreement (which resolved, among other things, the parties’ instant dispute regarding the challenged patent) with its motion, the Board dismissed the motion without prejudice to refile with the settlement agreement.

Read the full article at ptablitigationblog.com.

Jones Day publications should not be construed as legal advice on any specific facts or circumstances. The contents are intended for general information purposes only and may not be quoted or referred to in any other publication or proceeding without the prior written consent of the Firm, to be given or withheld at our discretion. To request reprint permission for any of our publications, please use our “Contact Us” form, which can be found on our website at www.jonesday.com. The mailing of this publication is not intended to create, and receipt of it does not constitute, an attorney-client relationship. The views set forth herein are the personal views of the authors and do not necessarily reflect those of the Firm.